Workflow
MetLife(MET) - 2024 Q4 - Annual Results
METMetLife(MET)2025-02-05 21:32

Revenue and Income - Total revenues for the year ended December 31, 2024, were 70,986million,anincreasefrom70,986 million, an increase from 66,905 million in 2023, representing a growth of approximately 3.2%[5] - Net income attributable to MetLife, Inc. for the year ended December 31, 2024, was 4,426million,comparedto4,426 million, compared to 4,444 million in 2023, showing a slight decrease of about 0.4%[5] - Premiums for the fourth quarter of 2024 were 12,617million,upfrom12,617 million, up from 10,647 million in the same quarter of 2023, reflecting a growth of approximately 18.5%[5] - Adjusted earnings available to common shareholders for the year ended December 31, 2024, were 52,520million,comparedto52,520 million, compared to 51,961 million in 2023, reflecting an increase of about 1.1%[5] - Net income available to common shareholders for Q4 2023 was 574million,increasingto574 million, increasing to 1,239 million by Q4 2024, representing a growth of 115%[6] - Adjusted earnings available to common shareholders for the year ended December 31, 2024, were 1,621million,upfrom1,621 million, up from 1,282 million in 2023, representing a growth of 26.5%[26] Expenses and Ratios - Total expenses for the year ended December 31, 2024, were 65,364million,aslightincreasefrom65,364 million, a slight increase from 64,743 million in 2023, indicating a growth of approximately 1%[5] - The expense ratio for the year ended December 31, 2024, was 19.0%, compared to 18.7% for the year ended December 31, 2023[14] - Direct expense ratio for the year ended December 31, 2024, was 10.7%, a decrease from 11.2% in the previous year[14] - The adjusted expense ratio for the year ended December 31, 2024, was 18.8%, slightly up from 18.6% in the previous year[14] - Total adjusted expenses for the three months ended December 31, 2024, were 2,273million,comparedto2,273 million, compared to 2,289 million in the previous year, showing a decrease of 0.7%[26] Investment Income - Net investment income for the year ended December 31, 2024, increased to 21,273millionfrom21,273 million from 19,908 million in 2023, marking a growth of about 6.8%[5] - Adjusted net investment income for the year ended December 31, 2024, is expected to reach 20,672million,anincreasefrom20,672 million, an increase from 19,749 million in 2023, indicating a growth of about 4.7%[12] - Variable investment income included in net investment income for the year ended December 31, 2024, is projected to be 1,013million,upfrom1,013 million, up from 419 million in 2023, showing a significant increase of about 141%[12] - The company reported net investment losses of (174)millioninQ42023,whichimprovedto(174) million in Q4 2023, which improved to (311) million in Q4 2024[6] Assets and Liabilities - The company’s total assets under management in Asia increased, with specific measures detailed in the financial supplement[3] - Total assets decreased to 677,457millionbyDecember31,2024,downfrom677,457 million by December 31, 2024, down from 704,976 million in September 2024[16] - The total liabilities as of December 31, 2024, were 649,754million,adecreasefrom649,754 million, a decrease from 673,812 million in September 2024[16] - The equity of MetLife, Inc. decreased to 27,703millionbyDecember31,2024,from27,703 million by December 31, 2024, from 31,164 million in September 2024[16] Future Growth and Strategy - Future policy benefits and policyholder account balances were highlighted as key areas for growth and focus in the upcoming fiscal year[3] - The company anticipates a stable growth trajectory in adjusted revenues and net investment income, driven by strategic market expansions and product innovations[12] Notable Items and Adjustments - Total notable items impacting adjusted earnings available to common shareholders were (76)millioninQ42023,withaslightrecoveryto(76) million in Q4 2023, with a slight recovery to 10 million in Q4 2024[6] - The company reported a net credit loss provision release and impairments of (67)millionforthethreemonthsendedDecember31,2023[43]ThecompanystotalnotableitemsfortheyearendedDecember31,2023,were(67) million for the three months ended December 31, 2023[43] - The company’s total notable items for the year ended December 31, 2023, were (62) million, compared to 26millionin2022,indicatinganegativeshiftinnotableitems[55]RegionalPerformanceAdjustedearningsavailabletocommonshareholdersforAsiaforQ42023were26 million in 2022, indicating a negative shift in notable items[55] Regional Performance - Adjusted earnings available to common shareholders for Asia for Q4 2023 were 291 million, with a forecast of 443millionforQ42024[67]LatinAmericareportedadjustedearningsof443 million for Q4 2024[67] - Latin America reported adjusted earnings of 182 million in Q4 2023, with a slight decrease to 201millionprojectedforQ42024[67]EMEAadjustedearningsforQ42023were201 million projected for Q4 2024[67] - EMEA adjusted earnings for Q4 2023 were 45 million, with a forecasted decrease to 59millioninQ42024[67]StockholderEquityMetLifescommonstockholdersequityasofDecember31,2023,was59 million in Q4 2024[67] Stockholder Equity - MetLife's common stockholders' equity as of December 31, 2023, was 26,197 million, with a book value per common share of 35.85[62]TheadjustedreturnonMetLifescommonstockholdersequityfortheyearendedDecember31,2023,was16.935.85[62] - The adjusted return on MetLife's common stockholders' equity for the year ended December 31, 2023, was 16.9%[62] - Adjusted common stockholders' equity, excluding total notable items, was 39,343 million as of December 31, 2023[62]